Binding of eukaryotic translation initiation factor 4E (eIF4E) to eIF4G represses translation of uncapped mRNA

被引:66
|
作者
Tarun, SZ [1 ]
Sachs, AB [1 ]
机构
[1] UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720
关键词
D O I
10.1128/MCB.17.12.6876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
mRNA translation in crude extracts from the yeast Saccharomyces cerevisiae is stimulated by the cap structure and the poly(A) tail through the binding of the cap-binding protein eukaryotic translation initiation factor 4E (eIF4E) and the poly(A) tail-binding protein Pab1p. These proteins also bind to the translation initiation factor eIF4G and thereby link the mRNA to the general translational apparatus. In contrast, uncapped, poly(A)-deficient mRNA is translated poorly in yeast extracts, in part because of the absence of eIF4E and Pab1p binding sites on the mRNA. Here, we report that uncapped-mRNA translation is also repressed in yeast extracts due to the binding of eIF4E to eIF4G, Specifically, we find that mutations which weaken the eIF4E binding site on the yeast eIF4G proteins Tif4631p and Tif4632p lead to temperature-sensitive growth in vivo and the stimulation of uncapped-mRNA translation in vitro. A mutation in eIF4E which disturbs its ability to interact with eIF4G also leads to a stimulation of uncapped-mRNA translation in vitro. Finally, overexpression of eIF4E in vivo or the addition of excess eIF4E in vitro reverses these effects of the mutations, These data support the hypothesis that the eIF4G protein can efficiently stimulate translation of exogenous untapped mRNA in extracts but is prevented from doing so as a result of its association with eIF4E. They also suggest that some mRNAs may be translationally regulated in vivo in response to the amount of free eIF4G in the cell.
引用
收藏
页码:6876 / 6886
页数:11
相关论文
共 50 条
  • [1] Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
    Hsieh, Andrew C.
    Ruggero, Davide
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (20) : 4914 - 4920
  • [2] The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer
    Karaki, Sara
    Andrieu, Claudia
    Ziouziou, Hajer
    Rocchi, Palma
    [J]. ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 101, 2015, 101 : 1 - 26
  • [3] TARGETING THE EUKARYOTIC TRANSLATION INITIATION FACTOR 4E (EIF4E) FOR CANCER THERAPY
    Graff, Jeremy R.
    [J]. ANTICANCER RESEARCH, 2008, 28 (5C) : 3300 - 3300
  • [4] The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
    Amorim, Ines S.
    Lach, Gilliard
    Gkogkas, Christos G.
    [J]. FRONTIERS IN GENETICS, 2018, 9
  • [5] Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation
    Ali, IK
    McKendrick, L
    Morley, SJ
    Jackson, RJ
    [J]. EMBO JOURNAL, 2001, 20 (15): : 4233 - 4242
  • [6] Interactions of the eukaryotic translation initiation factor eIF4E
    Gross, JD
    Matsuo, H
    Fletcher, M
    Sachs, AB
    Wagner, G
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 2001, 66 : 397 - 402
  • [7] Elevated eukaryotic translation initiation factor 4E (eIF4E) is involved in erlotinib resistance
    Li, Yikun
    Koo, Junghui
    Fan, Songqing
    Yue, Ping
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    Sun, Shi-Yon
    [J]. CANCER RESEARCH, 2011, 71
  • [8] Homeodomain proteins and eukaryotic translation initiation factor 4E (eIF4E): an unexpected relationship
    Topisirovic, I
    Borden, KLB
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (04) : 1275 - 1284
  • [9] The Role of Dynamics and Allostery in the Inhibition of the eIF4E/eIF4G Translation Initiation Factor Complex
    Salvi, Nicola
    Papadopoulos, Evangelos
    Blackledge, Martin
    Wagner, Gerhard
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (25) : 7176 - 7179
  • [10] Thermodynamics of mRNA 5′ cap binding by eukaryotic translation initiation factor eIF4E
    Niedzwiecka, A
    Darzynkiewicz, E
    Stolarski, R
    [J]. BIOCHEMISTRY, 2004, 43 (42) : 13305 - 13317